Results 91 to 100 of about 39,303 (298)
Imtinene Ben Mrad,1 Melek Ben Mrad,2 Zeineb Oumaya,1 Ihsen Zairi,1 Boutheina Besbes,1 Khalil Ouaghlani,1 Sofien kamoun,1 Sobhi Mleyhi,2 Rim Miri,2 khadija Mzoughi,1 Sondos Kraiem1 1Cardiology Department, Habib Thameur Hospital, Tunis, Tunisia ...
Ben Mrad I+10 more
doaj
Aims and Objectives: In vitro evaluation and comparison of thrombolytic activity of raw and purified bhallātaka (Semecarpus anacardium Linn.f.) nuts by means of % of clot lysis.
Dattatray D Sarvade+2 more
doaj +1 more source
The treatment and prevention of acute ischemic stroke [PDF]
Escola Paulista de Medicina Department of Internal MedicineUNIFESP, EPM, Department of Internal ...
Atallah, Álvaro Nagib
core +1 more source
Тромболизис в лечении острого тромбоза глубоких вен нижних конечностей [PDF]
ТРОМБОЛИТИЧЕСКАЯ ТЕРАПИЯТРОМБОЗКОНЕЧНОСТЬ ...
Царев, О. И.+1 more
core +1 more source
A prospective interventional study was carried out to compare the thrombolytic effect of streptokinase between diabetic and non-diabetic myocardial infarction patients.
Md. Anup Rahman Chowdhury+4 more
doaj +1 more source
BACKGROUND: Antistreptokinase antibody in serum of people who had been exposed to streptococcal infections may interfere with thrombolytic effects of streptokinase.
Hassan Shemirani+3 more
doaj
Transient acute renal failure after coronary thrombolysis with streptokinase
Introduction: There are currently more than 150 medications related to the appearance of rhabdomyolysis and transient acute renal failure. Streptokinase can be one of them.
Rodolfo Vega Candelario+1 more
doaj
Fibrinolytic Activity of Recombinant Mutant Streptokinase
Background: Streptokinase is a bacterial protein produced by different beta hemolytic streptococci and widely used in thrombolytic treatment. The main disadvantage of using streptokinase is antibody formation which causes allergic reaction to neutralize ...
Mahboobeh Mobarrez+3 more
doaj
Objective: Little is known about thrombolytic therapy patterns in patients with ST-elevation myocardial infarction (STEMI) in the Middle East. The objective of this study was to evaluate the clinical profile and mortality of STEMI patients who arrived in
Prashanth Panduranga+13 more
doaj +1 more source
BACKGROUND AND OBJECTIVE: Streptokinase (SK) is a microbial plasminogen-activator that is used in the treatments, especially at Acute ischemic stroke, declotting of dialysis shunts and inflammatory antibiotic-resistant prostatitis.
MR Nejadmoghaddam,+2 more
doaj